EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel replication-deficient FCV vaccine provides strong immune protection in cats

Wuchang Heng, Dan Zang, Ruiyu Li, Qian Jiang, Jiasen Liu iD, Honglin Jia iD, Hongtao Kang iD

Journal of Virology · 2025

DOI: 10.1128/jvi.00093-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Wuchang Heng und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbi…. Hauptthemen laut MEDLINE: Caliciviridae Infections, Viral Vaccines, Calicivirus, Feline, Cat Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Heilongjiang, National Natural Science Foundation of China, Central Public-interest Scientific Institution Basal Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Feline calicivirus (FCV) belongs to the family Caliciviridae, which includes important animal and human pathogens such as human norovirus and rabbit hemorrhagic disease virus. The fast evolution and great diversity of FCV make it highly difficult to develop vaccines that can induce sterilizing immunity. In this study, we evaluated the efficacy of a vaccine candidate generated via a replication-deficient vaccine strategy. Immunization with the vaccine generated a high level of neutralizing antibodies and highly reduced clinical outcomes against the challenge with a homologous virulent systemic feline calicivirus (VS-FCV) strain. Moreover, the VP1 gene of the vaccine was replaced with that derived from a heterologous virus strain. Vaccination with two combined virus constructs containing genetically distant VP1 genes led to the generation of broad neutralizing antibodies against FCV strains in cats. Notably, this replication-deficient FCV has the potential to serve as a viral vector vaccine, enabling the delivery of a foreign gene with stable genetics. In summary, this vaccine strategy holds great promise for developing safe, effective, and multivalent vaccines to prevent and control calicivirus infection. IMPORTANCE FCV is one of the leading causes of respiratory diseases in cats. Over the last 20 years, certain strains evolved into VS-FCV, with severe symptoms and increased fatality. Updating and developing vaccines promptly are essential. Here, we employed reverse genetics to partially delete the VP2 gene of FCV, rescuing the replication-deficient vaccine candidate rHBDL2 FCV-△VP2. Immunization with this candidate generated high levels of neutralizing antibodies against FCV strains and significantly reduced clinical symptoms. Furthermore, the adaptability of this replication-defective FCV platform holds potential for the development of viral vector vaccines as well as multivalent vaccines, which are also crucial for the prevention and control of other calicivirus infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caliciviridae InfectionsViral VaccinesCalicivirus, FelineCat DiseasesAnimalsCatsAntibodies, ViralAntibodies, NeutralizingVirus ReplicationVaccination

Stichwörter der Autor:innen

calicivirusreplication-deficient FCVvaccine

Substanzen

Viral VaccinesAntibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.
  • Heilongjiang Research Center for Veterinary Biopharmaceutical Technology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.

ORCID-Profile: Jiasen Liu, Honglin Jia, Hongtao Kang

Förderung

  • Key Research and Development Program of Heilongjiang
  • National Natural Science Foundation of China
  • Central Public-interest Scientific Institution Basal Research Fund

Zitieren

APA

Heng, W., Zang, D., Li, R., Jiang, Q., Liu, J., Jia, H., & Kang, H. (2025). A novel replication-deficient FCV vaccine provides strong immune protection in cats. Journal of Virology. https://doi.org/10.1128/jvi.00093-25

Vancouver

Heng W, Zang D, Li R, Jiang Q, Liu J, Jia H, et al. A novel replication-deficient FCV vaccine provides strong immune protection in cats. Journal of Virology. 2025. doi:10.1128/jvi.00093-25

BibTeX
@article{Heng2025,
  author = {Heng, Wuchang and Zang, Dan and Li, Ruiyu and Jiang, Qian and Liu, Jiasen and Jia, Honglin and Kang, Hongtao},
  title = {A novel replication-deficient FCV vaccine provides strong immune protection in cats},
  journal = {Journal of Virology},
  year = {2025},
  doi = {10.1128/jvi.00093-25}
}
Kostenlos starten →